Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzocaine/phenazone ear drops for acute otitis media in children
2014-004016-11Phase 4Completed
- Sponsor
- University of Bristol
- Start
- Aug 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Antipyrine + benzocaine, benzocaine and antipyrine in acute otitis media (AOM) (3 arms), sponsored by University of Bristol. Primary endpoint: Any antibiotic consumed by Day 8. Started Aug 2018; status: completed.
02
Drugs
Antipyrine + benzocainebenzocaineantipyrine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on 2014-004016-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004016-11.